Skip to main content
Caplight Logo









Ovitz

Ovitz

Private
Rochester, New YorkHealthcare & Life Scienceshttps://ovitz.us

Last Round

Accelerator

Jun 27, 2019

Total Funding Raised

$1.03M

Company Overview

Ovitz operates in Healthcare & Life Sciences and is based in Rochester, New York. Its latest recorded funding round was an Accelerator round in June 2019.

Ovitz is a medical technology company that develops portable ophthalmic equipment and wavefront-guided contact lens solutions to correct higher-order aberrations for patients with irregular corneas.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ovitz Comparables

Compare Ovitz with similar companies based on industry and business-model similarity.

Ovitz comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WaveFront Dynamics Inc.
85%
Eaglet Eye
81%
EyePrint Prosthetics
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ovitz Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 27, 2019
GrantSep 10, 2014
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Ovitz Investors

Notable investors and investment history

Ovitz investors
InvestorRounds
Empire State DevelopmentAccelerator
Luminate AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 44% MoM, reaching 4.4K.

  • Apr 21, 2026

    Grew 25% QoQ, from 12 to 15 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ovitz Filings

Explore SEC and related filing metadata, where available.

Ovitz filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ovitz's valuation, stock price, and market status.

Is Ovitz a public or private company?

Ovitz is a private company.

What is the current stock price of Ovitz?

Ovitz is a private company, so its shares have no public market price. Caplight tracks Ovitz's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ovitz worth (valuation)?

Valuation information for Ovitz is not publicly available.

Can I buy Ovitz stock?

Ovitz shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ovitz's last funding round?

Ovitz's most recent funding round was Accelerator on June 27, 2019.

Who are the main investors in Ovitz?

Key investors in Ovitz include Luminate Accelerator.

Will Ovitz IPO soon?

No public IPO plans have been announced for Ovitz.

How can I track Ovitz secondary market activity?

Caplight tracks bids, offers, and trades in Ovitz's shares on secondary markets.

Firmographic Details

HeadquartersRochester, New York
Employee Range2
Year Founded2017
Last FundingJun 27, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?